H7: Enteric Nervous System Alpha-Synuclein Propagation Blocker via Gut Barrier Restoration

Target: IL-22, REG3G, zonulin Composite Score: 0.595 Price: $0.61▲3.8% Citation Quality: Pending neurodegeneration Status: promoted

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

🟢 Parkinson's Disease 🧠 Neurodegeneration

✓ All Quality Gates Passed

Quality Report Card click to collapse

C+

Composite: 0.595

Top 13% of 513 hypotheses

T4 Speculative

Novel AI-generated, no external validation

Needs 1+ supporting citation to reach Provisional

B+ Mech. Plausibility 15% 0.78 Top 36%

B+ Evidence Strength 15% 0.72 Top 30%

C+ Novelty 12% 0.58 Top 93%

B+ Feasibility 12% 0.75 Top 29%

A Impact 12% 0.82 Top 22%

B+ Druggability 10% 0.70 Top 38%

B Safety Profile 8% 0.65 Top 31%

B Competition 6% 0.60 Top 69%

B Data Availability 5% 0.68 Top 50%

B+ Reproducibility 5% 0.72 Top 30%

Evidence

7 supporting | 3 opposing

Citation quality: 0%

Debates

0 sessions

No debates yet

Convergence

0.00 F 30 related hypothesis share this target

From Analysis:

How does engineered C. butyricum cross the blood-brain barrier to directly bind GLP-1 receptors?

The abstract claims C. butyricum-GLP-1 crosses the BBB and binds to GLP-1 receptors, but this is mechanistically implausible for a bacterial organism. The mechanism by which a gut bacterium could traverse the BBB and the actual source of GLP-1 receptor binding remains unexplained. Gap type: unexplained_observation Source paper: Engineered Clostridium butyricum-pMTL007-GLP-1 Delays Neurodegeneration in Prnp-SNCA*A53T Transgenic Mice Model by Suppressing Astrocyte Senescence. (2026, Probiotics and antimicrobial proteins, PMID:40627051)

→ View full analysis & debate transcript

Hypotheses from Same Analysis (1)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

H2: Indole-3-Propionate (IPA) as the Actual Neuroprotective Effector

Score: 0.675 | Target: PXR (NR1I2), IDO1

→ View full analysis & all 2 hypotheses

Description

Engineered C. butyricum restores intestinal barrier integrity via IL-22/Reg3 pathway activation, preventing alpha-synuclein fibril formation in enteric neurons and subsequent vagal propagation to the brain.

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

10 citations 7 with PMID Validation: 0% 7 supporting / 3 opposing

Evidence Matrix — sortable by strength/year, click Abstract to expand

Claim	Type	Source	Strength ↕	Year ↕	PMIDs	Abstract
C. butyricum restores intestinal barrier integrity…	Supporting	-	-	-	PMID:40879524	-
Bidirectional gut-to-brain and brain-to-gut propag…	Supporting	-	-	-	PMID:32380543	-
Prion-like propagation of alpha-synuclein in the g…	Supporting	-	-	-	PMID:29894766	-
Transneuronal propagation of pathologic alpha-synu…	Supporting	-	-	-	PMID:31255487	-
Gut-brain axis based on alpha-synuclein propagatio…	Supporting	-	-	-	PMID:40362234	-
Initiation of Parkinson's disease from gut to…	Supporting	-	-	-	PMID:31649329	-
Chitosan alleviates PD symptoms by decreasing acet…	Supporting	-	-	-	PMID:38934394	-
Intervention must occur before pathology is establ…	Opposing	-	-	-	-	-
Vagotomy is irreversible and not a therapeutic opt…	Opposing	-	-	-	-	-
Long-term effects of bacterial colonization unknow…	Opposing	-	-	-	-	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 7

C. butyricum restores intestinal barrier integrity via IL-22/Reg3 pathway following TBI

PMID:40879524

Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy documented in primates

PMID:32380543

Prion-like propagation of alpha-synuclein in the gut-brain axis established

PMID:29894766

Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson's disease

PMID:31255487

Gut-brain axis based on alpha-synuclein propagation shows clinical, neuropathological, and experimental eviden…▼

Gut-brain axis based on alpha-synuclein propagation shows clinical, neuropathological, and experimental evidence

PMID:40362234

Initiation of Parkinson's disease from gut to brain by delta-secretase

PMID:31649329

Chitosan alleviates PD symptoms by decreasing acetate levels, promoting intestinal and BBB repair

PMID:38934394

✗ Opposing Evidence 3

Intervention must occur before pathology is established; applicability to diagnosed patients is limited

Vagotomy is irreversible and not a therapeutic option

Long-term effects of bacterial colonization unknown

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

No linked debates yet. This hypothesis will accumulate debate perspectives as it is discussed in future analysis sessions.

Price History

7d Trend

↗

Rising

7d Momentum

▲ 3.8%

Volatility

High

0.0889

Events (7d)

⚡ Price Movement Log Recent 3 events

	Event	Price	Change	Source	Time
📄	New Evidence	$0.612	▼ 6.8%	evidence_update	2026-04-15 19:08
📄	New Evidence	$0.657	▲ 11.3%	evidence_update	2026-04-15 19:08
✨	Listed	$0.590		post_process	2026-04-15 19:08